🔎Chimiothérapie à base de platine pour le cancer du sein triple négatif au stade précoce 📚Revue @CochraneBCancer évaluant 20 études portant sur 4688 personnes ➡️Lire le résumé https://t.co/V2FlLLANwg @cochranecollab @CochraneCan_FR @CochraneBelgium @Coch
Platinum‐based chemotherapy for early triple‐negative breast cancer - Mason, SRE - 2023 | @cochranecollab #bcsm https://t.co/4WxeMRV3LN
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
Platinum-based chemotherapy in the adjuvant and neoadjuvant setting for people with triple-negative breast cancer - https://t.co/zDxFy9VxGq
RT @CochraneLibrary: Platinum‐containing #chemotherapy for early triple‐negative #breastcancer 🔎 📚 #SystematicReview - 20 studies 🌟 #Chem…
【コクランレビュー】早期のトリプルネガティブ乳癌への白金製剤ベースの化学療法（白金製剤を含む化学療法は、術前補助および術後補助の状況において無病生存期間および全生存期間を改善させた。） #ペ読 https://t.co/lVCuKx82Vs
Cochrane Review: Platinum‐based chemotherapy for early triple‐negative #breastcancer https://t.co/6B7Bd4On40 #Cancer
Platinum‐containing #chemotherapy for early triple‐negative #breastcancer 🔎 📚 #SystematicReview - 20 studies 🌟 #Chemo including the platinum‐based medicine carboplatin 🔼 survival & 🔽 chance of #cancer returning 🚩 associated with 🔼 side effects https
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @MartaPerachino: 🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR…
Carboplatin chemo improves disease-free survival and overall survival in early triple-negative breast cancer. Read our @CochraneLibrary review at the link below to see the full results following up on our abstract presented at 2022 @SABCSSanAntonio. http
RT @omalirp: Amazing work, Dr @sofiaremason! 👏🏾
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
UPDATE‼️
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @MartaPerachino: 🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
Superb
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
Chemotherapy including the platinum‐based medicine carboplatin improves survival and reduces the chance of cancer returning for people with early triple negative breast cancer, it is also associated with increased side effects. https://t.co/FsOu4RLh0v
RT @MartaPerachino: 🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR…
Amazing work, Dr @sofiaremason! 👏🏾
RT @MartaPerachino: 🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR…
RT @MartaPerachino: 🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR…
🚨 COCHRANE metanalysis of ➕ 💉CBDCA to (neo)adj CT in TNBC 📈 DFS in NEOADJ (HR 0.63) & ADJ (HR 0.69) 📈 OS in NEOADJ (HR 0.69) & ADJ (HR 0.70) 📈 pCR rates RR 1.44 ⬆️rates CT delays, dose reduction and discontinuation ❌ @Oncoalert #OncoalertAF h
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
⚠️⚠️⚠️
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
RT @dr_yakupergun: Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DF…
Platinum‐based chemotherapy for early triple‐negative breast cancer (Cochrane Database) 20 studies, 4.688 patients DFS and OS (Carbo)⬆️ Neoadj➡️HR: 0.63 and 0.69 Adj➡️HR 0.69 and 0.70 📌 Regardless of BRCA, HRD, LN positivity and anthracycline https://